SCICONX Journal of Drug and Alcohol

Welcome to the SCICONX Journal of Drug and Alcohol (JDA) - an open-access, peer-reviewed journal committed to advancing the scientific, clinical, and social understanding of substance use, addiction, and behavioral health. JDA serves as a multidisciplinary platform for original research, policy analysis, and clinical practice insights surrounding drug and alcohol-related issues.

With addiction and substance-related disorders posing complex global challenges, JDA fosters evidence-based dialogue that leads to informed policies, therapeutic breakthroughs, and compassionate care strategies.

✦ About the Journal

The SCICONX Journal of Drug and Alcohol is devoted to exploring the biological, psychological, social, and legal dimensions of substance use and dependency. We publish high-quality, ethically conducted studies and thoughtful perspectives that explore both the mechanisms and the consequences of drug and alcohol use - including prevention, intervention, harm reduction, and rehabilitation approaches.

We invite contributions from researchers, clinicians, behavioral scientists, policy analysts, public health experts, and recovery advocates.

✦ Scope of the Journal

JDA publishes content that spans a wide and evolving field, including:

• Neurobiology of addiction
• Behavioral patterns and dependency cycles
• Substance use disorders in youth and aging populations
• Psychosocial impacts of alcohol and drug misuse
• Dual diagnosis and co-occurring mental health conditions
• Treatment models and recovery pathways
• Rehabilitation and relapse prevention
• Public health, epidemiology, and harm reduction
• Criminal justice, drug policy, and decriminalization research
• Digital therapeutics, mobile interventions, and AI-assisted care
• Gender, trauma, and cultural factors in addiction science

✦ What Makes JDA Unique?

• Transdisciplinary Approach: We bring together diverse voices from medicine, psychology, public policy, and lived experience.
• Open Access for Real-World Impact: Free access ensures research informs practice, policy, and advocacy worldwide.
• Ethical and Inclusive Publishing: We are committed to publishing research that respects human dignity, community perspectives, and cultural variation.
• Rapid but Rigorous Review: Submissions are peer-reviewed under a double-blind model with prompt editorial decisions.

✦ Fast Editorial Execution and Review Process (FEE-Review Process)

Authors who are willing to publish their articles under this mode can make a pre-payment of € 99 towards express peer-review and editorial decision. First editorial decision in 3 days and final decision with review comments in 5 days from the date of submission. Galley proof generation will be done in next 2 days from acceptance or maximum 5 days (For manuscripts notified for revision by external reviewer). 

Manuscripts accepted for publication will be charged regular APC.

Authors retain the copyright of their publication and the final version of the article will be published in both HTML and PDF formats as well as XML formats for transmitting to indexing databases. The editorial team of the Journal will ensure adherence to scientific publication guidelines.

✦ Call for Contributions

JDA welcomes original research articles, systematic reviews, clinical case reports, short communications, and position papers. We particularly encourage submissions from underrepresented regions and marginalized communities affected by substance use.

✦ Join the Movement Toward Evidence-Based Recovery

At JDA, we believe research is not just about understanding addiction - it’s about transforming lives, shaping compassionate policies, and driving healing. Be part of the next wave of impact in drug and alcohol studies.